These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22391876)

  • 1. The effects of temozolomide delivered by prolonged intracerebral microinfusion against the rat brainstem GBM allograft model.
    Yoshimura J; Siu IM; Thomale UW; Jallo GI
    Childs Nerv Syst; 2012 May; 28(5):707-13. PubMed ID: 22391876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin.
    Grossman R; Tyler B; Hwang L; Zadnik P; Lal B; Javaherian K; Brem H
    J Neurosurg; 2011 Dec; 115(6):1139-46. PubMed ID: 21923243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.
    Banissi C; Ghiringhelli F; Chen L; Carpentier AF
    Cancer Immunol Immunother; 2009 Oct; 58(10):1627-34. PubMed ID: 19221744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model.
    Vellimana AK; Recinos VR; Hwang L; Fowers KD; Li KW; Zhang Y; Okonma S; Eberhart CG; Brem H; Tyler BM
    J Neurooncol; 2013 Feb; 111(3):229-36. PubMed ID: 23224713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
    Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
    Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.
    Verreault M; Wehbe M; Strutt D; Masin D; Anantha M; Walker D; Chu F; Backstrom I; Kalra J; Waterhouse D; Yapp DT; Bally MB
    J Control Release; 2015 Dec; 220(Pt A):348-357. PubMed ID: 26528901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
    Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T
    Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study.
    Szczepanek D; Marchel A; Moskała M; Krupa M; Kunert P; Trojanowski T
    Neurol Neurochir Pol; 2013; 47(2):101-8. PubMed ID: 23649997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.
    Carlson BL; Grogan PT; Mladek AC; Schroeder MA; Kitange GJ; Decker PA; Giannini C; Wu W; Ballman KA; James CD; Sarkaria JN
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):212-9. PubMed ID: 19695438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.
    Masi BC; Tyler BM; Bow H; Wicks RT; Xue Y; Brem H; Langer R; Cima MJ
    Biomaterials; 2012 Aug; 33(23):5768-75. PubMed ID: 22591609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma.
    Chamberlain MC; Chalmers L
    J Neurooncol; 2007 Apr; 82(2):207-9. PubMed ID: 17019532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
    Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
    Grossman SA; Ye X; Piantadosi S; Desideri S; Nabors LB; Rosenfeld M; Fisher J;
    Clin Cancer Res; 2010 Apr; 16(8):2443-9. PubMed ID: 20371685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.
    Heimberger AB; Archer GE; McLendon RE; Hulette C; Friedman AH; Friedman HS; Bigner DD; Sampson JH
    Clin Cancer Res; 2000 Oct; 6(10):4148-53. PubMed ID: 11051269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
    Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
    J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
    Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A
    Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.